A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait

Randall D. Little(NKT Therapeutics (United States)), Mark L. Johnson(Creighton University), Susan P. Manning(NKT Therapeutics (United States)), Anthony Caruso, Anthony Anisowicz, Michael G. FitzGerald(Broad Institute), Peter T. Lomedico, Mark A. Osborne(Takeda (Japan)), Alicia Bawa(NKT Therapeutics (United States)), Susan M. Recker(Creighton University), Colleen Folz(NKT Therapeutics (United States)), Ronald Adair, Robert R. Recker(Creighton University), Josée Dupuis(Boston University), Susan Zweier, Youssef Benchekroun(NKT Therapeutics (United States)), Paul Van Eerdewegh, Brenda K. Eustace, Xavier Nogués(Creighton University), Xintong Hu, Karen Braunschweiger(NKT Therapeutics (United States)), Richard G. Del Mastro(NKT Therapeutics (United States)), Michelle M. Lappe(Creighton University), Shan-Chuan Zhao(Takeda (Japan)), Nia Tzellas, Lia Spitzer, Pamela Swain(National Institutes of Health), Kristina M. Allen(NKT Therapeutics (United States)), Barbara Franklin, Linda Chee(Takeda (Japan)), John P. Carulli(Biogen (United States)), Arturo J. Morales, Craig Tulig(Takeda (Japan)), Gordon Gong(Creighton University), Shannon McGuire(Creighton University)
The American Journal of Human Genetics
January 1, 2002
Cited by 1,293


Related Papers